9/24/2013
Investor Presentation of the Week
Medient Studios, Inc. (“Medient”) is intending to build an intellectual property factory that, creates commercial content to a fill vacuum in market demand, produces movies and electronic games a at significantly lower cost than the competition, benefits from substantial tax incentives support, extends its content horizontally to increase revenues with limited additional costs, and is led by a proven and stable management team which has been reinforced by a battery of industry and finance professionals.

Medient Studios, Inc. (MDNT)
Free signup
  • FREE RESEARCH REPORTS ($250 value)
  • WEEKLY BRIEFINGS ON EMERGING GROWTH COMPANIES

Galectin Therapeutics, Inc. (GALT): The Next Big Thing in Fibrotic Disease and Cancer Treatment - Part 1

Galectin Therapeutics, Inc. (GALT): The Next Big Thing in Fibrotic Disease and Cancer Treatment

Tobin Smith of NBT Equities Research interviews James Czirr of Galectin Therapeutics, Inc. (GALT)

©2010-2012 NBT Group. All Rights Reserved  |  Privacy Policy
Website Design by Amanda Besemer + Co.